or Try an Advanced Search...

    Technical Analysis for IMVT - Immunovant, Inc.

    Grade Last Price % Change Price Change
    D 27.51 4.20% 1.11
    IMVT closed up 4.2 percent on Monday, July 1, 2024, on 1.17 times normal volume. It ran into resistance at its 50 day moving average.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical IMVT trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Crossed Above 20 DMA Bullish 4.20%
    Pocket Pivot Bullish Swing Setup 4.20%
    Outside Day Range Expansion 4.20%
    20 DMA Resistance Bearish 5.81%
    NR7 Range Contraction 5.81%
    Narrow Range Bar Range Contraction 5.81%
    Down 3 Days in a Row Weakness 5.81%
    Fell Below 20 DMA Bearish 5.56%
    Older End-of-Day Signals for IMVT ...

       Recent Intraday Alerts

    Alert Time
    Upper Bollinger Band Resistance about 7 hours ago
    50 DMA Resistance about 8 hours ago
    Rose Above Upper Bollinger Band about 8 hours ago
    Up 5% about 8 hours ago
    Up 1 ATR about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    IMVT Chart by TradingView
    Basic chart:

    Profile

    Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It is developing IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Immune System Autoimmune Disease Eye Antibodies Monoclonal Antibodies Monoclonal Antibody Anemia Thyroid Eye Diseases Treatment Of Autoimmune Disease Myasthenia Gravis Transfusion Medicine Myasthenia Thyroid Eye Disease Acquired Hemolytic Anemia Treatment Of Myasthenia Gravis

    Is IMVT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 Immunovant (IMVT) Down 1.6% Since Last Earnings Report: Can It Rebound?
    Jun 28 Immunovant: Overvalued Amidst M&A Speculation
    Jun 27 Immunovant: Next Generation Anti-FcRn Candidate Keeps Hopes Alive
    May 31 Q4 2024 Roivant Sciences Ltd Earnings Call
    May 30 After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
    May 30 Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
    May 30 Immunovant changes up plans for closely watched autoimmune drugs
    May 29 Immunovant GAAP EPS of -$0.52 misses by $0.08
    May 29 Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024
    May 29 Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
    See more IMVT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 45.58
    52 Week Low 18.1615
    Average Volume 1,182,755
    200-Day Moving Average 33.45
    50-Day Moving Average 27.87
    20-Day Moving Average 26.18
    10-Day Moving Average 26.82
    Average True Range 1.25
    RSI (14) 53.05
    ADX 13.24
    +DI 27.61
    -DI 19.26
    Chandelier Exit (Long, 3 ATRs) 24.89
    Chandelier Exit (Short, 3 ATRs) 28.42
    Upper Bollinger Bands 27.82
    Lower Bollinger Band 24.53
    Percent B (%b) 0.9
    BandWidth 12.58
    MACD Line -0.32
    MACD Signal Line -0.52
    MACD Histogram 0.2037
    Fundamentals Value
    Market Cap 3.98 Billion
    Num Shares 145 Million
    EPS -1.96
    Price-to-Earnings (P/E) Ratio -14.04
    Price-to-Sales 0.00
    Price-to-Book 20.38
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 31.08
    Resistance 3 (R3) 31.06 29.85 30.49
    Resistance 2 (R2) 29.85 28.94 29.86 30.29
    Resistance 1 (R1) 28.68 28.38 29.27 28.70 30.09
    Pivot Point 27.47 27.47 27.76 27.48 27.47
    Support 1 (S1) 26.30 26.56 26.89 26.32 24.93
    Support 2 (S2) 25.09 26.00 25.10 24.73
    Support 3 (S3) 23.92 25.09 24.54
    Support 4 (S4) 23.94